Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 43 Records) |
| Query Trace: Syndrome and MEN1[original query] |
|---|
| Novel MEN 1 gene findings in rare sporadic insulinoma--a case control study. BMC endocrine disorders 2015 15 (1): 44. Jyotsna Viveka P, Malik Ekta, Birla Shweta, Sharma Arundha |
| Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1. Journal of cellular and molecular medicine 2015 Jul 19 (7): 1735-41. Circelli Luisa, Ramundo Valeria, Marotta Vincenzo, Sciammarella Concetta, Marciello Francesca, Del Prete Michela, Sabatino Lina, Pasquali Daniela, Izzo Francesco, Scala Stefania, Colao Annamaria, Faggiano Antongiulio, Colantuoni Vittorio, |
| Histologic and Molecular Profile of Pediatric Insulinomas: Evidence of a Paternal Parent-of-Origin Effect. The Journal of clinical endocrinology and metabolism 2016 Jan jc20152914. Bhatti Tricia R, Ganapathy Karthik, Huppmann Alison R, Conlin Laura, Boodhansingh Kara E, MacMullen Courtney, Becker Susan, Ernst Linda M, Adzick N Scott, Ruchelli Eduardo D, Ganguly Arupa, Stanley Charles |
| Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome. Endocrine connections 2017 9 6 (8): 557-565. Mamedova Elizaveta, Mokrysheva Natalya, Vasilyev Evgeny, Petrov Vasily, Pigarova Ekaterina, Kuznetsov Sergey, Kuznetsov Nikolay, Rozhinskaya Liudmila, Melnichenko Galina, Dedov Ivan, Tiulpakov Anato |
| Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features. PloS one 2017 10 12 (10): e0186485. Pardi Elena, Borsari Simona, Saponaro Federica, Bogazzi Fausto, Urbani Claudio, Mariotti Stefano, Pigliaru Francesca, Satta Chiara, Pani Fabiana, Materazzi Gabriele, Miccoli Paolo, Grantaliano Lorena, Marcocci Claudio, Cetani Filome |
| MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM. Transactions of the American Clinical and Climatological Association 2017 1 127 235-244. Arnold Andr |
| A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins. Hormones (Athens, Greece) 2018 8 17 (3): 427-435. Palermo Andrea, Capoluongo Ettore, Del Toro Rossella, Manfrini Silvia, Pozzilli Paolo, Maggi Daria, Defeudis Giuseppe, Pantano Francesco, Coppola Roberto, Di Matteo Francesco Maria, Raffaelli Marco, Concolino Paola, Falchetti Alber |
| Clinical implication of MEN1 mutation in surgically resected thymic carcinoid patients. Journal of thoracic disease 2018 4 10 (2): E125-E129. Li Xiongfei, Li Mingbiao, Shi Tao, Liu Renwang, Ren Dian, Yang Fan, Wei Sen, Chen Gang, Chen Jun, Xu So |
| Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database. Endocrine 2018 3 62 (1): 215-233. Marini Francesca, Giusti Francesca, Fossi Caterina, Cioppi Federica, Cianferotti Luisella, Masi Laura, Boaretto Francesca, Zovato Stefania, Cetani Filomena, Colao Annamaria, Davì Maria Vittoria, Faggiano Antongiulio, Fanciulli Giuseppe, Ferolla Piero, Ferone Diego, Loli Paola, Mantero Franco, Marcocci Claudio, Opocher Giuseppe, Beck-Peccoz Paolo, Persani Luca, Scillitani Alfredo, Guizzardi Fabiana, Spada Anna, Tomassetti Paola, Tonelli Francesco, Brandi Maria Lui |
| Screening of AIP Gene Variations in a Cohort of Turkish Patients with Young-Onset Sporadic Hormone-Secreting Pituitary Adenomas. Genetic testing and molecular biomarkers 2018 Nov . Tuncer Feyza Nur, Çiftçi Do?an?en Sema, Serbest Esin, Tanr?kulu Seher, Ekici Yeliz, Bilgiç Bilge, Yarman Se |
| The efficacy of everolimus and sunitinib in patients with sporadic or germline mutated metastatic pancreatic neuroendocrine tumors. Journal of gastrointestinal oncology 2019 8 10 (4): 645-651. Nuñez Jose Eduardo, Donadio Mauro, Filho Duilio Rocha, Rego Juliana Florinda, Barros Milton, Formiga Maria Nirvana, Lopez Rossana, Riechelmann Rach |
| True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome. Endocrine 2019 May . Kövesdi Annamária, Tóth Miklós, Butz Henriett, Szücs Nikolette, Sármán Beatrix, Pusztai Péter, Toke Judit, Reismann Péter, Fáklya Mónika, Tóth Géza, Somogyi Anikó, Borka Katalin, Erdei Annamária, Nagy Endre V, Deák Veronika, Valkusz Zsuzsanna, Igaz Péter, Patócs Attila, Grolmusz Vince Korn |
| Novel Mutations in Serbian MEN1 Patients: Genotype-phenotype Correlation. Journal of medical biochemistry 2019 Mar 38 (1): 38-44. Isailovic Tatjana, Milicevic Ivana, Macut Djuro, Petakov Milan, Ognjanovic Sanja, Popovic Bojana, Antic Ivana Bozic, Bogavac Tamara, Kovacevic Valentina Elezovic, Ilic Dusan, Damjanovic Svetoz |
| Exome Sequencing in BRCA1- and BRCA2-Negative Greek Families Identifies MDM1 and NBEAL1 as Candidate Risk Genes for Hereditary Breast Cancer. Frontiers in genetics 2019 10 1005. Glentis Stavros, Dimopoulos Alexandros C, Rouskas Konstantinos, Ntritsos George, Evangelou Evangelos, Narod Steven A, Mes-Masson Anne-Marie, Foulkes William D, Rivera Barbara, Tonin Patricia N, Ragoussis Jiannis, Dimas Antigone |
| Whole genome sequencing of apparently mutation-negative MEN1 patients. European journal of endocrinology 2019 10 182 (1): 35-45. Backman Samuel, Bajic Duska, Crona Joakim, Hellman Per, Skogseid Britt, Stålberg Pet |
| Three Novel MEN1 Variants in AIP-Negative Familial Isolated Pituitary Adenoma Patients. Pathobiology : journal of immunopathology, molecular and cellular biology 2019 Jan 1-7. Yarman Sema, Tuncer Feyza Nur, Serbest Es |
| Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. JAMA oncology 2020 Mar . Mirabello Lisa, Zhu Bin, Koster Roelof, Karlins Eric, Dean Michael, Yeager Meredith, Gianferante Matthew, Spector Logan G, Morton Lindsay M, Karyadi Danielle, Robison Leslie L, Armstrong Gregory T, Bhatia Smita, Song Lei, Pankratz Nathan, Pinheiro Maisa, Gastier-Foster Julie M, Gorlick Richard, de Toledo Silvia Regina Caminada, Petrilli Antonio S, Patino-Garcia Ana, Lecanda Fernando, Gutierrez-Jimeno Miriam, Serra Massimo, Hattinger Claudia, Picci Piero, Scotlandi Katia, Flanagan Adrienne M, Tirabosco Roberto, Amary Maria Fernanda, Kurucu Nilgün, Ilhan Inci Ergurhan, Ballinger Mandy L, Thomas David M, Barkauskas Donald A, Mejia-Baltodano Gerardo, Valverde Patricia, Hicks Belynda D, Zhu Bin, Wang Mingyi, Hutchinson Amy A, Tucker Margaret, Sampson Joshua, Landi Maria T, Freedman Neal D, Gapstur Susan, Carter Brian, Hoover Robert N, Chanock Stephen J, Savage Sharon |
| Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomas. European journal of endocrinology 2021 7 185 (4): 485-496. Martínez de LaPiscina Idoia, Portillo Najera Nancy, Rica Itxaso, Gaztambide Sonia, Webb Susan M, Santos Alicia, Moure Maria Dolores, Paja Fano Miguel, Hernandez Maria Isabel, Chueca-Guindelain Maria Jesús, Hernández-Ramírez Laura Cristina, Soto Alfonso, Valdés Nuria, Castaño Lu |
| A Parathyroid-Gut Axis: Hypercalcemia and the Pathogenesis of Gastrinoma in Multiple Endocrine Neoplasia 1. Molecular cancer research : MCR 2021 3 19 (6): 946-949. Hackeng Wenzel M, Dreijerink Koen M A, Offerhaus G Johan A, Brosens Lodewijk A |
| Massive parallel sequencing in individuals with multiple primary tumours reveals the benefit of re-analysis. Hereditary cancer in clinical practice 2021 10 19 (1): 46. Wallander Karin, Thonberg Håkan, Nilsson Daniel, Tham Em |
| Two Distinct Classes of Thymic Tumors in Patients with MEN1 Show LOH at the MEN1 Locus. Endocrine-related cancer 2021 Sep . Mandl Adel, Welch James M, Kapoor Gayathri, Parekh Vaishali I, Schrump David S, Ripley R Taylor, Walter Mary F, Del Rivero Jaydira, Jha Smita, Simonds William F, Jensen Robert T, Weinstein Lee S, Blau Jenny E, Agarwal Sunita |
| The Importance of Periodical Screening for Primary Hyperparathyroidism in a Pituitary Tumor Cohort in Searching Patients With MEN1 and Its Genetic Profile. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2022 Mar . Damianse Sabrina S P, Nascimento Gilvan C, Rocha Viviane C C, Nascimento Ana Gisélia P A C, Gaido Nadja C, Azulay Rossana S S, Dos Santos Wellyandra C, Rodrigues Vandilson P, Quidute Ana Rosa P, Magalhães Marcelo, Dos S Faria Manu |
| Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutation. BMC endocrine disorders 2022 3 22 (1): 64. Welsch Christoph, Flügel Anna Katharina, Rondot Susanne, Schulze Egbert, Sircar Ishani, Nußbaumer Judith, Bojunga Jö |
| [MEN for multiple endocrin neoplasms: When evokate MEN? Update 2022]. La Revue de medecine interne 2022 10 44 (1): 12-18. Duval M, Haissaguerre |
| Germline CDKN1B variant type and site are associated with phenotype in MEN4. Endocrine-related cancer 2022 10 30 (1): . Halperin Reut, Arnon Liat, Nasirov Sapir, Friedensohn Limor, Gershinsky Michal, Telerman Alona, Friedman Eitan, Bernstein-Molho Rinat, Tirosh Am |
| Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome. Frontiers in endocrinology 2023 7 14 1191040. Laura Pierotti, Elena Pardi, Elisa Dinoi, Paolo Piaggi, Simona Borsari, Simone Della Valentina, Chiara Sardella, Angela Michelucci, Maria Adelaide Caligo, Fausto Bogazzi, Claudio Marcocci, Filomena Ceta |
| Clinical profile and treatment outcomes among patients with sporadic and multiple endocrine neoplasia syndrome-related primary hyperparathyroidism. Clinical endocrinology 2023 7 . Uthara E Mathew, Alpesh Goyal, Ashish D Upadhyay, Devasenathipathy Kandasamy, Shipra Agarwal, Chitresh K Sharma, Arundhati Sharma, Chandrasekhar Bal, Nikhil Tandon, Viveka P Jyots |
| [Casuistic cases of parathyroid carcinoma with a verified mutation in the MEN1 gene]. Problemy endokrinologii 2023 2 69 (1): 15-27. Pylina S V, Kim E I, Bondarenko E V, Krupinova J A, Eremkina A K, Mokrysheva N |
| Familial parathyroid tumours-comparison of clinical profiles between syndromes. Journal of endocrinological investigation 2023 2 . Figueiredo A A, Saramago A, Cavaco B M, Simões-Pereira J, Leite |
| The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study. Cancers 2024 5 16 (9): . Mark Ayoub, Carol Faris, Tajana Juranovic, Harleen Chela, Ebubekir Daglil |
- Page last reviewed:Feb 1, 2024
- Content source: